Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nebulized Dexmedetomidine vs Midazolam for Sedation in C-Section
NCT04873596Phase 2Recruiting
- Sponsor
- Zagazig University
- Start
- May 2021
- Primary completion
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of dexmedetomidine in Procedural sedation (PS) (2 arms), sponsored by Zagazig University. Primary endpoint: Change in the level of sedation. Started May 2021; status: recruiting.
02
Drugs
dexmedetomidine
03
Conditions
Procedural sedation (PS)
Beyond the preview
Go deeper on NCT04873596.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04873596.